Gene · 445
NIH grants1,983
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 1,983
Download this page as JSON| Grant | Title | ASS1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 1 | 2025 |
| R01CA204302 | Characterization of YAP as a rational companion target in lung cancer | 1 | 2025 |
| R01CA205420 | Enhancing miRNA Therapeutics through Vehicle Free Delivery | 1 | 2025 |
| R01CA215185 | Nutrient Regulation of Cancer Cell Growth | 1 | 2025 |
| R01CA224550 | Glutamine synthetase in beta-catenin driven hepatocellular carcinoma | 1 | 2025 |
| R01CA225958 | Novel bioengineered microRNA therapeutics for lung cancer | 1 | 2025 |
| R01CA226259 | Ligand-mediated, vehicle-free delivery of small RNAs | 1 | 2025 |
| R01CA237347 | Elucidate the mechanism of autophagy in supporting Lkb1-deficient lung tumorigenesis and metastasis | 1 | 2025 |
| R01CA240290 | Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells | 1 | 2025 |
| R01CA250227 | Investigating multifactorial beta-catenin activation in hepatocellular cancers | 1 | 2025 |
| R01CA252225 | Defining metabolic adaptations within the PDAC "arid" tumor microenvironment | 1 | 2025 |
| R01CA254970 | Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy | 1 | 2025 |
| R01CA256989 | Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance | 1 | 2025 |
| R01CA259253 | Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism | 1 | 2025 |
| R01CA279550 | Mechanisms Promoting Copper Dependent Cell Death in Cancer | 1 | 2025 |
| R01DK037175 | Protein Nutrition in Experimental Uremia | 1 | 2025 |
| R01DK058110 | Dose-Dependent Effects of Hormone on the Activity of Estrogen Receptor Enhancers and Target Genes | 1 | 2025 |
| R01DK061931 | Mechanisms and pathophysiologic impact of claudin-2 modulation | 1 | 2025 |
| R01DK064640 | Transcription factors in kidney development | 1 | 2025 |
| R01DK095201 | Control of iron absorption by intestinal HIF2 in iron and hematological disorders | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/grants?page=11